Isophthalic Acid

Isophthalic Acid

SCHEMBL1250697

O=C(O)c1cccc(C(=O)O)c1.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.67
ALOX15 P16050 1/20 0.67
KDM4E B2RXH2 1/20 0.64
AKR1C3 P42330 2/20 0.64
KMO O15229 1/20 0.59
DAO P14920 1/20 0.59
TSHR P16473 1/20 0.59
NAPRT Q6XQN6 1/20 0.59
MEN1 O00255 1/20 0.58
PKM P14618 1/20 0.58
KMT2A Q03164 1/20 0.58
POLB P06746 1/20 0.58
CA12 O43570 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
CA6 P23280 1/20 0.58
CA9 Q16790 1/20 0.58
PTPN1 P18031 1/20 0.57
ATM Q13315 1/20 0.56
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terephthalic Acid SCHEMBL5914459 0.96 KDM4E (0.66) ALDH1A1ALOX15KDM4EAKR1C3KMO
Isophthalic Acid SCHEMBL10796566 0.92 CA12 (0.67) ALDH1A1ALOX15KDM4EAKR1C3KMO
Isophthalic Acid SCHEMBL8394374 0.92 KDM4E (0.56) ALDH1A1ALOX15KDM4EAKR1C3KMO
SCHEMBL2058538 0.92 AKR1C3 (0.73) ALDH1A1ALOX15KDM4EAKR1C3KMO
Isophthalic Acid SCHEMBL14778536 0.89 KMO (0.53) ALDH1A1ALOX15KDM4EAKR1C3KMO
Pyromellitic Acid SCHEMBL16242783 0.88 CA12 (0.60) KDM4EAKR1C3KMODAOTSHR
Phthalic Acid SCHEMBL30665138 0.87 TSHR (0.78) ALDH1A1ALOX15KDM4EAKR1C3DAO
Phthalic Acid SCHEMBL322997 0.87 TSHR (0.78) ALDH1A1ALOX15KDM4EAKR1C3DAO
Phthalic Acid SCHEMBL4578569 0.87 TSHR (0.78) ALDH1A1ALOX15KDM4EAKR1C3DAO
Isophthalic Acid SCHEMBL147366 0.87 CA12 (0.71) AKR1C3KMODAOTSHRNAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023111923-A1 A BIODEGRADABLE POLYMER AND A PROCESS FOR ITS PREPARATION RELIANCE INDUSTRIES LIMITED (IN) 2023-06-22 WO claimed
US-5939582-A Reaction control by regulating internal condensation inside a reactor TWENTY-FIRST CENTURY RESEARCH CORPORATION (US) 1999-08-17 US claimed
US-20240055020-A1 OPTICAL STORAGE MEDIUM UNIV CASE WESTERN RESERVE (US) 2024-02-15 US disclosed
US-11840617-B2 Stabilizer composition, vinyl chloride resin composition containing same, and article molded therefrom ADEKA CORPORATION (JP) 2023-12-12 US disclosed
US-11798589-B2 Optical storage medium CASE WESTERN RESERVE UNIVERSITY (US) 2023-10-24 US disclosed
US-20220415351-A1 OPTICAL STORAGE MEDIUM FOLIO PHOTONICS, INC. 2022-12-29 US disclosed
US-20220068306-A1 OPTICAL INFORMATION STORAGE MEDIUM NATIONAL SCIENCE FOUNDATION 2022-03-03 US disclosed
EP-3939038-A1 OPTICAL INFORMATION STORAGE MEDIUM Case Western Reserve University (US) 2022-01-19 EP disclosed
US-11211091-B2 Optical information storage medium CASE WESTERN RESERVE UNIVERSITY (US) 2021-12-28 US disclosed
US-20210340315-A1 CASHEW NUT SHELL LIQUID DERIVATIVES AND METHODS FOR MAKING AND USING SAME CARDOLITE CORPORATION (US) 2021-11-04 US disclosed
US-20210113984-A1 METHOD FOR PREPARING CAPSULES COMPRISING AT LEAST ONE VOLATILE COMPOUND AND CAPSULES OBTAINED THEREFROM CALYXIA (FR) 2021-04-22 US disclosed
US-4749804-A Preparation of stereoisomers of ketals SYNTEX (U.S.A.) INC. (US) 1988-06-07 US disclosed
EP-0242465-A1 Anthracene polyarylate copolymers and alloy compositions thereof CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1987-10-28 EP disclosed
EP-0084643-B1 A PROCESS FOR PREPARING GRAFT AND BLOCK COPOLYMERS ALLIED CORPORATION (US) 1987-03-04 EP disclosed
US-4568720-A WITH PHOSPHITE COMPOUND ALLIED CHEMICAL CORPORATION (US) 1986-02-04 US disclosed
US-4417031-A HEATING POLYMER MIXTURE IN PRESENCE OF PHOSPHITE COMPOUND ALLIED CORPORATION (US) 1983-11-22 US disclosed
EP-0084643-A1 A process for preparing graft and block copolymers ALLIED CORPORATION (US) 1983-08-03 EP disclosed
EP-0081993-A2 Optically active alpha-substituted aryl ketones, their preparation and their use in preparing alpha-arylalkanoic acids SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1983-06-22 EP disclosed
US-4336343-A CONTAINING SODIUM CITRATE MORRIS TOWNSHIP, MORRIS COUNTY (US) 1982-06-22 US disclosed
US-4085260-A Powder coating compositions with hydroxy containing acrylic copolymers-I and carboxylic acid or anhydride crosslinking agent FORD MOTOR COMPANY (US) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340315-A1 CASHEW NUT SHELL LIQUID DERIVATIVES AND METHODS FOR MAKING AND USING SAME DSG1, TAS1R3, LPO ALDH1A1 1721/4885ALOX15 507/4885KDM4E 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.